Oncoinvent ASA (OSL:ONCIN)
80.20
-0.80 (-0.99%)
Aug 4, 2026, 3:56 PM CET
Oncoinvent ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28.07 | 8.1 | 0.35 | 6.28 | 0.77 | |
Revenue Growth | 246.40% | 2188.98% | -94.37% | 711.76% | 28.79% |
Gross Profit | 28.07 | 8.1 | 0.35 | 6.28 | 0.77 |
Selling, General & Admin | 69.72 | 59.08 | -55.61 | 53.38 | -74.05 |
Depreciation & Amortization Expenses | 11.25 | 14.56 | -0.22 | 7.99 | -1.31 |
Other Operating Expenses | 105.43 | 75.49 | -136.35 | 55.53 | -239.88 |
Total Operating Expenses | 186.4 | 149.12 | -192.17 | 116.89 | -315.24 |
Operating Income | -158.33 | -141.02 | -191.82 | -110.61 | -314.46 |
Interest Income | 4.1 | 1.55 | - | - | - |
Other Non-Operating Income (Expense) | 3.26 | 0.82 | 1.42 | 4.33 | 5.1 |
Total Non-Operating Income (Expense) | 7.36 | 2.36 | 1.42 | 4.33 | 5.1 |
Pretax Income | -150.97 | -138.65 | -190.4 | -106.28 | -309.36 |
Net Income | -150.97 | -138.65 | -190.4 | -106.28 | -309.36 |
Net Income to Common | -155.07 | -140.2 | -190.4 | -106.28 | -309.36 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 124 | 25 | 14 | 1 | 1 |
Shares Outstanding (Diluted) | 124 | 25 | 14 | 1 | 1 |
Shares Change | 395.91% | 74.59% | 1527.28% | - | 17.40% |
EPS (Basic) | -1.25 | -5.61 | -13.00 | -548.00 | -352.00 |
EPS (Diluted) | -1.25 | -5.61 | -13.00 | -548.00 | -352.00 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -129.99 | -89.75 | -225.1 | -93.17 | -303.34 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -1.05 | -3.59 | -15.73 | -105.93 | -344.88 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -564.07% | -1740.32% | -54186.20% | -1760.48% | -40628.40% |
Profit Margin | -537.84% | -1711.14% | -53785.60% | -1691.55% | -39969.50% |
FCF Margin | -463.11% | -1107.55% | -63587.90% | -1482.94% | -39191.20% |
EBITDA | -147.08 | -126.46 | -191.6 | -102.62 | -313.15 |
EBITDA Margin | -523.99% | -1560.69% | -54123.20% | -1633.36% | -40458.90% |
EBIT | -158.33 | -141.02 | -191.82 | -110.61 | -314.46 |
EBIT Margin | -564.07% | -1740.32% | -54186.20% | -1760.48% | -40628.40% |